Influenza Vaccines Research & Development Roadmap

Influenza Vaccines Research & Development Roadmap is a global collaboration dedicated to accelerating the development of improved seasonal and universal influenza vaccines. Recognizing the ongoing threat of influenza pandemics worldwide, the organization has produced the world's first global roadmap designed to leverage advances in vaccine science and technology, inspired by breakthroughs seen in COVID-19 vaccine development. This initiative is backed by prominent organizations including the Wellcome Trust and coordinated by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.

Influenza Vaccines Research & Development Roadmap has engaged over 100 stakeholder organizations representing public and private sector perspectives from 29 countries. The core mission revolves around two pivotal goals: enhancing the production and effectiveness of strain-specific seasonal vaccines and fostering the development, licensure, and production of universal influenza vaccines. This comprehensive approach aims to significantly improve global preparedness and mitigation strategies against future influenza outbreaks.

The organization's roadmap outlines a detailed ten-year plan for achieving these ambitious objectives. By embracing this strategy, the world can effectively tame seasonal epidemics and swiftly respond to potential pandemics. Influenza Vaccines Research & Development Roadmap is committed to a future where influenza poses a significantly diminished global health threat. We invite you to explore how we can collaborate to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach.